Year |
Citation |
Score |
2023 |
Zeitouny S, Cheung DC, Bremner KE, Pataky RE, Pequeno P, Matelski J, Peacock S, Del Giudice ME, Lapointe-Shaw L, Tomlinson G, Mendlowitz AB, Mulder C, Tsui TCO, Perlis N, Walker JD, ... Sander B, et al. The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis. Plos One. 18: e0290646. PMID 37682823 DOI: 10.1371/journal.pone.0290646 |
0.501 |
|
2023 |
Sahakyan Y, Abrahamyan L, Ratjen F, Bear C, Strug L, Eckford PDW, Peel JK, Krahn M, Sander B. Cost-effectiveness analysis of genetic tools to predict treatment response in patients with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 37100704 DOI: 10.1016/j.jcf.2023.04.013 |
0.427 |
|
2023 |
Mendlowitz AB, Bremner KE, Krahn M, Walker JD, Wong WWL, Sander B, Jones L, Isaranuwatchai W, Feld JJ. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 195: E499-E512. PMID 37040993 DOI: 10.1503/cmaj.220717 |
0.44 |
|
2022 |
Tsui TCO, Zeitouny S, Bremner KE, Cheung DC, Mulder C, Croxford R, Del Giudice L, Lapointe-Shaw L, Mendlowitz A, Wong WWL, Perlis N, Sander B, Teckle P, Tomlinson G, Walker JD, et al. Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study. Cmaj Open. 10: E818-E830. PMID 36126976 DOI: 10.9778/cmajo.20210328 |
0.509 |
|
2022 |
Cheung DC, Bremner KE, Tsui TCO, Croxford R, Lapointe-Shaw L, Giudice LD, Mendlowitz A, Perlis N, Pataky RE, Teckle P, Zeitouny S, Wong WWL, Sander B, Peacock S, Krahn MD, et al. "Bring the Hoses to Where the Fire Is!": Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. PMID 35527165 DOI: 10.1016/j.jval.2022.03.019 |
0.511 |
|
2022 |
Welie AG, Stolk E, Mukuria C, Belay YB, Krahn MD, Sander B, Gebretekle GB. Reliability and validity of using EQ-5D-5L among healthy and adolescents with major mental health disorders in Ethiopia. The European Journal of Health Economics : Hepac : Health Economics in Prevention and Care. PMID 35013918 DOI: 10.1007/s10198-021-01412-y |
0.4 |
|
2021 |
Tam DY, Qiu F, Manoragavan R, Fremes SE, Hassan A, Ko DT, Lauck SB, Naimark D, Ouzounian M, Sander B, Sun L, Wijeysundera HC. The Impact of the COVID-19 Pandemic on Cardiac Procedure Wait List Mortality in Ontario, Canada. The Canadian Journal of Cardiology. PMID 34600793 DOI: 10.1016/j.cjca.2021.05.008 |
0.388 |
|
2021 |
Mendlowitz A, Bremner KE, Walker JD, Wong WWL, Feld JJ, Sander B, Jones L, Isaranuwatchai W, Krahn M. Hepatitis C virus infection in First Nations populations in Ontario from 2006 to 2014: a population-based retrospective cohort analysis. Cmaj Open. 9: E886-E896. PMID 34584007 DOI: 10.9778/cmajo.20200164 |
0.424 |
|
2021 |
Mendlowitz A, Bremner KE, Walker JD, Wong WWL, Feld JJ, Sander B, Jones L, Isaranuwatchai W, Krahn M. Health care costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study. Cmaj Open. 9: E897-E906. PMID 34584004 DOI: 10.9778/cmajo.20200247 |
0.488 |
|
2021 |
Wong WWL, Haines A, Bremner KE, Yao Z, Calzavara A, Mitsakakis N, Kwong JC, Sander B, Thein HH, Krahn MD. Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study. Cmaj Open. 9: E167-E174. PMID 33688024 DOI: 10.9778/cmajo.20200162 |
0.522 |
|
2020 |
Parmar A, Richardson M, Coyte PC, Cheng S, Sander B, Chan KKW. A cost-utility analysis of atezolizumab in the second-line treatment of patients with metastatic bladder cancer. Current Oncology (Toronto, Ont.). 27: e386-e394. PMID 32905260 DOI: 10.3747/Co.27.5459 |
0.339 |
|
2020 |
Ramsay LC, Shing E, Wang J, Marras TK, Kwong JC, Brode SK, Jamieson FB, Sander B. Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001-2012. Emerging Infectious Diseases. 26: 2097-2107. PMID 32818392 DOI: 10.3201/Eid2609.190524 |
0.353 |
|
2020 |
Miranda RN, Ximenes R, Gebretekle GB, Bielecki JM, Sander B. Health-Related Quality of Life in Neurological Disorders Most Commonly Associated With Zika-Virus Infection: A Systematic Review. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 23: 969-976. PMID 32762999 DOI: 10.1016/J.Jval.2020.03.004 |
0.322 |
|
2020 |
Tam DY, Naimark D, Natarajan MK, Woodward G, Oakes G, Rahal M, Barrett K, Khan YA, Ximenes R, Mac MBiotech S, Sander B, Wijeysundera HC. The Use of Decision Modelling to Inform Timely Policy Decisions on Cardiac Resource Capacity during the COVID-19 Pandemic. The Canadian Journal of Cardiology. PMID 32447059 DOI: 10.1016/J.Cjca.2020.05.024 |
0.478 |
|
2020 |
Barrett K, Khan YA, Mac S, Ximenes R, Naimark DMJ, Sander B. Estimation of COVID-19-induced depletion of hospital resources in Ontario, Canada. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. PMID 32409519 DOI: 10.1503/Cmaj.200715 |
0.318 |
|
2020 |
Besar Sa'aid H, Mathew S, Richardson M, Bielecki JM, Sander B. Mapping the evidence on health equity considerations in economic evaluations of health interventions: a scoping review protocol. Systematic Reviews. 9: 6. PMID 31915067 DOI: 10.1186/S13643-019-1257-4 |
0.322 |
|
2020 |
Mukerji A, Shafey A, Jain A, Cohen E, Shah PS, Sander B, Shah V. Pulse oximetry screening for critical congenital heart defects in Ontario, Canada: a cost-effectiveness analysis. Canadian Journal of Public Health = Revue Canadienne De Sante Publique. PMID 31907759 DOI: 10.17269/S41997-019-00280-7 |
0.353 |
|
2019 |
Anyiwe K, Richardson M, Brophy J, Sander B. Assessing adolescent immunization options for pertussis in Canada: A cost-utility analysis. Vaccine. PMID 31889607 DOI: 10.1016/J.Vaccine.2019.12.021 |
0.341 |
|
2019 |
MacDougall C, Johnstone J, Prematunge C, Adomako K, Nadolny E, Truong E, Saedi A, Garber G, Sander B. Economic Evaluation of Vancomycin-Resistant Enterococci (VRE) Control Practices: A Systematic Review. The Journal of Hospital Infection. PMID 31857122 DOI: 10.1016/J.Jhin.2019.12.007 |
0.301 |
|
2019 |
Shing E, Wang J, Nelder MP, Parpia C, Gubbay JB, Loeb M, Kristjanson E, Marchand-Austin A, Moore S, Russell C, Sider D, Sander B. The direct healthcare costs attributable to West Nile virus illness in Ontario, Canada: a population-based cohort study using laboratory and health administrative data. Bmc Infectious Diseases. 19: 1059. PMID 31847823 DOI: 10.1186/S12879-019-4596-9 |
0.41 |
|
2019 |
Ramsay LC, Crowcroft NS, Thomas S, Aruffo E, Teslya A, Heffernan JM, Gournis E, Hiebert J, Jaeger V, Jiaravuthisan M, Sharron J, Severini A, Deeks SL, Gubbay J, Mazzulli T, ... Sander B, et al. Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 24. PMID 30892178 DOI: 10.2807/1560-7917.ES.2019.24.11.1800370 |
0.315 |
|
2019 |
Mac S, Silva SRd, Sander B. The Economic Burden of Lyme Disease and the Cost-Effectiveness of Lyme Disease Interventions: A Scoping Review Plos One. 14. PMID 30608986 DOI: 10.1371/Journal.Pone.0210280 |
0.394 |
|
2018 |
Raphael J, Sun Z, Bjarnason GA, Helou J, Sander B, Naimark DM. Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma: A Cost-Utility Analysis. American Journal of Clinical Oncology. PMID 29727313 DOI: 10.1097/Coc.0000000000000451 |
0.348 |
|
2018 |
Mallya S, Sander B, Roy-Gagnon MH, Taljaard M, Jolly A, Kulkarni MA. Factors associated with human West Nile virus infection in Ontario: a generalized linear mixed modelling approach. Bmc Infectious Diseases. 18: 141. PMID 29587649 DOI: 10.1186/S12879-018-3052-6 |
0.32 |
|
2018 |
Zangneh H, Wong W, Sander B, Bell C, Mumtaz K, Kowgier M, Van der Meer A, Cleary S, Janssen H, Chan K, Feld J. Cost-effectiveness analysis of hepatocellular carcinoma screening in hepatitis C cirrhosis after sustained viral response Journal of Hepatology. 68: S34. DOI: 10.1016/S0168-8278(18)30286-1 |
0.319 |
|
2017 |
D'Souza R, Shah PS, Sander B. Clinical decision analysis in perinatology. Acta Obstetricia Et Gynecologica Scandinavica. PMID 29164601 DOI: 10.1111/Aogs.13264 |
0.308 |
|
2017 |
Yeung MW, Tomlinson G, Loeb M, Sander B. Health-related quality of life in persons with West Nile virus infection: a longitudinal cohort study. Health and Quality of Life Outcomes. 15: 210. PMID 29061146 DOI: 10.1186/S12955-017-0787-5 |
0.329 |
|
2017 |
Luca DL, Kwong JC, Chu A, Sander B, O'Reilly R, McGeer AJ, Bloom DE. Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29029063 DOI: 10.1093/Cid/Cix850 |
0.361 |
|
2017 |
Yeung MW, Shing E, Nelder M, Sander B. Epidemiologic and clinical parameters of West Nile virus infections in humans: a scoping review. Bmc Infectious Diseases. 17: 609. PMID 28877682 DOI: 10.1186/S12879-017-2637-9 |
0.314 |
|
2017 |
Thomas S, Hiebert J, Gubbay JB, Gournis E, Sharron J, Severini A, Jiaravuthisan M, Shane A, Jaeger V, Crowcroft NS, Fediurek J, Sander B, Mazzulli T, Schulz H, Deeks SL. Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015. Emerging Infectious Diseases. 23: 1063-1069. PMID 28628461 DOI: 10.3201/Eid2307.161145 |
0.307 |
|
2017 |
Ting EE, Sander B, Ungar WJ. Systematic review of the cost-effectiveness of influenza immunization programs. Vaccine. PMID 28284681 DOI: 10.1016/J.Vaccine.2017.02.044 |
0.348 |
|
2017 |
Nanwa N, Sander B, Krahn M, Daneman N, Lu H, Austin PC, Govindarajan A, Rosella LC, Cadarette SM, Kwong JC. A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions. Plos One. 12: e0172410. PMID 28257438 DOI: 10.1371/Journal.Pone.0172410 |
0.518 |
|
2017 |
Lapointe-Shaw L, Voruganti T, Kohler P, Thein HH, Sander B, McGeer A. Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. PMID 28078557 DOI: 10.1007/S10096-016-2890-7 |
0.344 |
|
2017 |
DʼSouza R, Tomlinson G, McKelvey K, Krahn M, Murphy K, Sander B. Preferences of Pregnant Women and Family Members for Health States Arising From Anticoagulant Use in Pregnancy [17N] Obstetrics & Gynecology. 129. DOI: 10.1097/01.Aog.0000514727.34878.0A |
0.44 |
|
2016 |
McGirr AA, Schwartz KL, Allen U, Solomon M, Sander B. The Cost-Effectiveness of Palivizumab in Infants with Cystic Fibrosis in the Canadian Setting: A Decision Analysis Model. Human Vaccines & Immunotherapeutics. 0. PMID 27768505 DOI: 10.1080/21645515.2016.1235670 |
0.35 |
|
2016 |
Nanwa N, Kwong JC, Krahn M, Daneman N, Lu H, Austin PC, Govindarajan A, Rosella LC, Cadarette SM, Sander B. The Economic Burden of Hospital-Acquired Clostridium difficile Infection: A Population-Based Matched Cohort Study. Infection Control and Hospital Epidemiology. 1-11. PMID 27322606 DOI: 10.1017/Ice.2016.122 |
0.552 |
|
2016 |
Yeung MW, Khoo E, Brode SK, Jamieson FB, Kamiya H, Kwong JC, Macdonald L, Marras TK, Morimoto K, Sander B. Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review. Respirology (Carlton, Vic.). PMID 27009804 DOI: 10.1111/Resp.12767 |
0.312 |
|
2016 |
Sander B, Wong WW, Yeung MW, Ormanidhi O, Atkin K, Murphy J, Krahn M, Deeks SL. The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting - Can we do better? Vaccine. PMID 26892739 DOI: 10.1016/J.Vaccine.2016.02.016 |
0.498 |
|
2015 |
Strifler L, Morris SK, Dang V, Tu HA, Minhas RS, Jamieson FB, Deeks SL, Crowcroft NS, Sander B. The Health Burden of Invasive Meningococcal Disease: A Systematic Review. Journal of the Pediatric Infectious Diseases Society. PMID 26501470 DOI: 10.1093/Jpids/Piv065 |
0.327 |
|
2015 |
Patel H, Sander B, Nelder MP. Long-term sequelae of West Nile virus-related illness: a systematic review Lancet Infectious Diseases. 15: 951-959. PMID 26163373 DOI: 10.1016/S1473-3099(15)00134-6 |
0.3 |
|
2015 |
Nanwa N, Kendzerska T, Krahn M, Kwong JC, Daneman N, Witteman W, Mittmann N, Cadarette SM, Rosella L, Sander B. The economic impact of Clostridium difficile infection: a systematic review. The American Journal of Gastroenterology. 110: 511-9. PMID 25848925 DOI: 10.1038/Ajg.2015.48 |
0.513 |
|
2015 |
Thampi N, Gurol-Urganci I, Crowcroft NS, Sander B. Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis. Plos One. 10. PMID 25747269 DOI: 10.1371/Journal.Pone.0119271 |
0.398 |
|
2015 |
Farhang Zangneh H, Wong W, Sander B, Bell C, Mumtaz K, Kowgier M, Van Der Meer A, Cleary S, Chan K, Feld J. P0330 : Cost-effectiveness analysis of hepatocellular carcinoma surveillance in patients with hepatitis C related cirrhosis after sustained virological response Journal of Hepatology. 62: S433. DOI: 10.1016/S0168-8278(15)30545-6 |
0.314 |
|
2014 |
Tu HA, Deeks SL, Morris SK, Strifler L, Crowcroft N, Jamieson FB, Kwong JC, Coyte PC, Krahn M, Sander B. Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada. Vaccine. 32: 5436-46. PMID 25131732 DOI: 10.1016/J.Vaccine.2014.07.096 |
0.525 |
|
2014 |
Strifler L, Morris S, Dang V, Tu H, Minhas R, Jamieson F, Deeks S, Crowcroft N, Sander B. 164: The Health Burden of Invasive Meningococcal Disease: A Systematic Review Paediatrics and Child Health. 19. DOI: 10.1093/Pch/19.6.E35-160 |
0.302 |
|
2011 |
Pham B, Stern A, Chen W, Sander B, John-Baptiste A, Thein HH, Gomes T, Wodchis WP, Bayoumi A, Machado M, Carcone S, Krahn M. Preventing pressure ulcers in long-term care: a cost-effectiveness analysis. Archives of Internal Medicine. 171: 1839-47. PMID 21949031 DOI: 10.1001/Archinternmed.2011.473 |
0.534 |
|
2011 |
Pereira JA, Foisy J, Kwong JC, Heidebrecht CL, Quach S, Quan SD, Guay M, Sander B. A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns. Bmc Health Services Research. 11: 210. PMID 21880158 DOI: 10.1186/1472-6963-11-210 |
0.359 |
|
2011 |
Arino J, Bauch C, Brauer F, Driedger SM, Greer AL, Moghadas SM, Pizzi NJ, Sander B, Tuite A, van den Driessche P, Watmough J, Wu J, Yan P. Pandemic influenza: Modelling and public health perspectives. Mathematical Biosciences and Engineering : Mbe. 8: 1-20. PMID 21361397 DOI: 10.3934/Mbe.2011.8.1 |
0.322 |
|
2011 |
Andradóttir S, Chiu W, Goldsman D, Lee ML, Tsui KL, Sander B, Fisman DN, Nizam A. Reactive strategies for containing developing outbreaks of pandemic influenza. Bmc Public Health. 11: S1. PMID 21356128 DOI: 10.1186/1471-2458-11-S1-S1 |
0.312 |
|
2010 |
Sander B, Bauch CT, Fisman D, Fowler RA, Kwong JC, Maetzel A, McGeer A, Raboud J, Scales DC, Gojovic MZ, Krahn M. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience Vaccine. 28: 6210-6220. PMID 20643091 DOI: 10.1016/J.Vaccine.2010.07.010 |
0.557 |
|
2010 |
Sander B, Kwong JC, Bauch CT, Maetzel A, McGeer A, Raboud JM, Krahn M. Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis. Plos Medicine. 7: e1000256. PMID 20386727 DOI: 10.1371/Journal.Pmed.1000256 |
0.524 |
|
2009 |
Sander B, Bauch C, Fisman DN, Fowler R, Kwong JC, McGeer A, Gojovic MZ, Krahn M. Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian Experience. Plos Currents. 1. PMID 20043032 DOI: 10.1371/Currents.Rrn1137 |
0.535 |
|
2009 |
Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT. Modelling mitigation strategies for pandemic (H1N1) 2009 Canadian Medical Association Journal. 181: 673-680. PMID 19825923 DOI: 10.1503/Cmaj.091641 |
0.512 |
|
2009 |
Talbird SE, Brogan AJ, Winiarski AP, Sander B. Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States American Journal of Health-System Pharmacy. 66: 469-480. PMID 19233995 DOI: 10.2146/Ajhp080296 |
0.418 |
|
2008 |
Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. The Journal of Bone and Joint Surgery. American Volume. 90: 1197-205. PMID 18519311 DOI: 10.2106/Jbjs.G.00980 |
0.321 |
|
2006 |
Sander B, Hayden FG, Gyldmark M, Garrison LP. Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK. Pharmacoeconomics. 24: 373-86. PMID 16605283 DOI: 10.2165/00019053-200624040-00007 |
0.397 |
|
2005 |
Sander B, Gyldmark M, Hayden FG, Morris J, Mueller E, Bergemann R. Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United Kingdom. The European Journal of Health Economics : Hepac : Health Economics in Prevention and Care. 6: 244-52. PMID 15875227 DOI: 10.1007/S10198-005-0297-Y |
0.415 |
|
2004 |
Reisinger K, Greene G, Aultman R, Sander B, Gyldmark M. Effect of influenza treatment with oseltamivir on health outcome and costs in otherwise healthy children. Clinical Drug Investigation. 24: 395-407. PMID 17516726 DOI: 10.2165/00044011-200424070-00003 |
0.377 |
|
2004 |
Butler JRG, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B. The cost-effectiveness of pneumococcal conjugate vaccination in Australia Vaccine. 22: 1138-1149. PMID 15003641 DOI: 10.1016/J.Vaccine.2003.09.036 |
0.39 |
|
2004 |
Sander B, Gyldmark M, Aultman R, Aoki FY. Impact on health outcome and costs of influenza treatment with oseltamivir in elderly and high-risk patients Journal of Medical Economics. 7: 67-83. DOI: 10.3111/200407067083 |
0.422 |
|
2003 |
Sander B, Bergemann R. Economic burden of obesity and its complications in Germany. European Journal of Health Economics. 4: 248-253. PMID 15609192 DOI: 10.1007/S10198-003-0178-1 |
0.324 |
|
2003 |
Sander B, Gyldmark M, Bergemann R, Garrison L. Pin14 Post-Exposure Influenza Prophylaxis With Oseltamivir: Cost-Effectiveness And Cost-Utility In Families In The Uk Value in Health. 6: 750. DOI: 10.1016/S1098-3015(10)61911-0 |
0.37 |
|
2002 |
Sander B, Gyldmark M, Morris J, Bergemann R. Pin16 Influenza Treatment With Oseltamivir In A High Risk Population—A Costeffective Option For The Health Care Payer Value in Health. 5: 567-568. DOI: 10.1016/S1098-3015(10)61494-5 |
0.329 |
|
Show low-probability matches. |